BCG-MEDAC, poudre et solvant pour suspension intravésicale, PD1IL2v iMAb
BP45381
Phase 2 small_molecule active
Quick answer
BCG-MEDAC, poudre et solvant pour suspension intravésicale, PD1IL2v iMAb for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) is a Phase 2 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active